Knowing what's growing: Why ductal and intraductal prostate cancer matter

被引:25
|
作者
Lawrence, Mitchell G. [1 ,2 ,3 ]
Porter, Laura H. [1 ]
Clouston, David [4 ]
Murphy, Declan G. [3 ,5 ,6 ]
Frydenberg, Mark [1 ,7 ,8 ]
Taylor, Renea A. [2 ,3 ,9 ]
Risbridger, Gail P. [1 ,2 ,3 ]
机构
[1] Monash Univ, Monash Biomed Discovery Inst, Dept Anat & Dev Biol,Canc Program, Monash Partners Comprehens Canc Consortium,Prosta, Clayton, Vic 3800, Australia
[2] Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic 3000, Australia
[3] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia
[4] TissuPath, Mt Waverley, Vic 3149, Australia
[5] Univ Melbourne, Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic 3000, Australia
[6] Epworth HealthCare, Melbourne, Vic 3000, Australia
[7] Australian Urol Associates, Melbourne, Vic 3000, Australia
[8] Cabrini Hlth, Dept Urol, Malvern, Vic 3144, Australia
[9] Monash Univ, Monash Biomed Discovery Inst, Dept Physiol,Canc Program, Monash Partners Comprehens Canc Consortium,Prosta, Clayton, Vic 3800, Australia
基金
英国医学研究理事会;
关键词
PATIENT-DERIVED XENOGRAFTS; ISUP CONSENSUS CONFERENCE; GENITAL ORGANS-PART; GLEASON PATTERN 4; INTRAEPITHELIAL NEOPLASIA; NEEDLE-BIOPSY; MOUSE MODELS; PTEN LOSS; CLINICOPATHOLOGICAL CHARACTERISTICS; HISTOPATHOLOGICAL FEATURES;
D O I
10.1126/scitranslmed.aaz0152
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostate cancer is a common malignancy, but only some tumors are lethal. Accurately identifying these tumors will improve clinical practice and instruct research. Aggressive cancers often have distinctive pathologies, including intraductal carcinoma of the prostate (IDC-P) and ductal adenocarcinoma. Here, we review the importance of these pathologies because they are often overlooked, especially in genomics and preclinical testing. Pathology, genomics, and patient-derived models show that IDC-P and ductal adenocarcinoma accompany multiple markers of poor prognosis. Consequently, "knowing what is growing" will help translate preclinical research to pinpoint and treat high-risk prostate cancer in the clinic.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Life and Death, Knowledge and Power: Why Knowing What Matters Is Not What's the Matter
    Katz, David L.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (15) : 1362 - 1363
  • [2] Oncological outcomes of men with ductal and intraductal prostate cancer treated with prostatectomy: a single centre analysis
    Zargar, H.
    Hovens, C.
    Peters, J.
    Norden, S.
    Ryan, A.
    Costello, A.
    Corcoran, N.
    [J]. BJU INTERNATIONAL, 2016, 117 : 112 - 112
  • [3] The what, when, and why of human prostate cancer xenografts
    Brennen, W. Nathaniel
    Isaacs, John T.
    [J]. PROSTATE, 2018, 78 (09): : 646 - 654
  • [4] Nature's disvalues: what are they and why do they matter?
    Lliso, Bosco
    Lenzi, Dominic
    Muraca, Barbara
    Chan, Kai M. A.
    Pascual, Unai
    [J]. CURRENT OPINION IN ENVIRONMENTAL SUSTAINABILITY, 2022, 56
  • [5] Vanuatu's Growing Body of Literature Why Women's Voices Matter
    Nyman, Mikaela
    [J]. WORLD LITERATURE TODAY, 2022, 96 (01) : 10 - 14
  • [6] What's disgusting, why, and what does it matter? (Emotion, revulsion, food)
    Jones, MO
    [J]. JOURNAL OF FOLKLORE RESEARCH, 2000, 37 (01) : 53 - 71
  • [7] Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer
    Velho, Pedro Isaacsson
    Silberstein, John L.
    Markowski, Mark C.
    Luo, Jun
    Lotan, Tamara L.
    Isaacs, William B.
    Antonarakis, Emmanuel S.
    [J]. PROSTATE, 2018, 78 (05): : 401 - 407
  • [8] Prostate Cancer Imaging: What, Why, and When (CME Credit Available)
    Figueiras, Garcia R.
    Vilanova, J.
    Patel, S.
    Caamano, Gomez A.
    Gonzalez, Baleato S.
    Martin, Villalba C.
    Bermudez, A.
    Padhani, A.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 192 (05)
  • [9] What's Wrong With Chemoprevention of Prostate Cancer?
    Justman, Stewart
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2011, 11 (12): : 21 - 25
  • [10] Hormones and prostate cancer: What's next?
    Hsing, AW
    [J]. EPIDEMIOLOGIC REVIEWS, 2001, 23 (01) : 42 - 58